{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:22:18Z","timestamp":1761502938419,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772273","81902145"],"award-info":[{"award-number":["81772273","81902145"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jmoldx.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T10:55:42Z","timestamp":1586861742000},"page":"876-884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continual Improvement of the Reliability of EML4-ALK Rearrangement Detection in Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Rongxue","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1426-2354","authenticated-orcid":false,"given":"Ping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guigao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiehong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1476-3397","authenticated-orcid":false,"given":"Jinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2020.03.007_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-40389-2_7","article-title":"Multimodality therapy for NSCLC","volume":"170","author":"Du","year":"2016","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14737140.2018.1409624","article-title":"Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer","volume":"18","author":"Nagasaka","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10408363.2017.1299683","article-title":"Using circulating cell-free DNA to monitor personalized cancer therapy","volume":"54","author":"Oellerich","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/annonc\/mdy512","article-title":"Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping","volume":"30","author":"Zugazagoitia","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib6","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/JTO.0000000000000280","article-title":"ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first Italian external quality assurance scheme","volume":"9","author":"Marchetti","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.phrs.2017.01.007","article-title":"Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers","volume":"117","author":"Roskoski","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hoc.2016.08.012","article-title":"Diagnosis and treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer","volume":"31","author":"Arbour","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2174\/0929867323666161029223823","article-title":"Recent development in the discovery of anaplastic lymphoma kinase (ALK) inhibitors for non-small cell lung cancer","volume":"24","author":"Liu","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib10","first-page":"70","article-title":"Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements","volume":"3","author":"Teixido","year":"2014","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/COC.0000000000000213","article-title":"Diagnosis of EML4-ALK translocation with FISH, immunohistochemistry, and real-time polymerase chain reaction in patients with non-small cell lung cancer","volume":"40","author":"Cruz-Rico","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib12","first-page":"38","article-title":"Value of immunohistochemical methods in detecting EML4-ALK fusion mutations: a meta-analysis","volume":"19","author":"Liu","year":"2016","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2016.11.008","volume":"103","author":"von Laffert","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JOP.2014.002303","volume":"11","author":"Rekhtman","year":"2015","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib15","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/j.jtho.2016.04.022","article-title":"Reliability assurance of EML4-ALK rearrangement detection in non-small cell lung cancer: a methodological and statistical issue","volume":"11","author":"Sabour","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib16","doi-asserted-by":"crossref","first-page":"50477","DOI":"10.18632\/oncotarget.10464","article-title":"Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib17","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.18632\/oncotarget.13741","article-title":"Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1373\/clinchem.2011.168641","article-title":"Proficiency testing\/external quality assessment: current challenges and future directions","volume":"57","author":"Miller","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib19","doi-asserted-by":"crossref","first-page":"20524","DOI":"10.18632\/oncotarget.24980","article-title":"A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer","volume":"9","author":"Keppens","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.lungcan.2013.04.015","article-title":"Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing","volume":"81","author":"Laffert","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib21","doi-asserted-by":"crossref","first-page":"e112159","DOI":"10.1371\/journal.pone.0112159","article-title":"The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization","volume":"9","author":"Tembuyser","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/PAI.0000000000000267","article-title":"Developing ALK immunohistochemistry and in situ hybridization proficiency testing for non-small cell lung cancer in Canada: Canadian immunohistochemistry quality control challenges and successes","volume":"23","author":"Cheung","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib23","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jtho.2016.07.012","article-title":"ALK immunohistochemistry in NSCLC: discordant staining can impact patient treatment regimen","volume":"11","author":"Ibrahim","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jtho.2016.03.004","article-title":"Reliability assurance of detection of EML4-ALK rearrangement in non-small cell lung cancer: the results of proficiency testing in China","volume":"11","author":"Li","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-012-1354-4","article-title":"Guideline on the requirements of external quality assessment programs in molecular pathology","volume":"462","author":"van Krieken","year":"2013","journal-title":"Virchows Arch"},{"year":"2010","series-title":"ISO\/IEC 17043: 2010 Conformity Assessment\u2014General Requirements for Proficiency Testing","key":"10.1016\/j.jmoldx.2020.03.007_bib26"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jmoldx.2017.06.003","article-title":"CRISPR\/Cas9 technology-based xenograft tumors as candidate reference materials for multiple EML4-ALK rearrangements testing","volume":"19","author":"Peng","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1186\/s12885-018-5070-6","article-title":"RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC\/FISH discordance","volume":"18","author":"Vollbrecht","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1183\/09031936.00119914","article-title":"French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas","volume":"46","author":"Lantuejoul","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib30","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1158\/1078-0432.CCR-11-2947","article-title":"A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer","volume":"18","author":"Soda","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib31","doi-asserted-by":"crossref","first-page":"e000419","DOI":"10.1136\/esmoopen-2018-000419","article-title":"ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?","volume":"3","author":"Cabillic","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.jmoldx.2020.03.007_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tranon.2018.11.006","article-title":"Discordance between FISH, IHC, and NGS analysis of ALK status in advanced non-small cell lung cancer (NSCLC): a brief report of 7 cases","volume":"12","author":"Scattone","year":"2019","journal-title":"Transl Oncol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157820300933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157820300933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:14:36Z","timestamp":1761502476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157820300933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1525157820300933"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2020.03.007","relation":{},"ISSN":["1525-1578"],"issn-type":[{"type":"print","value":"1525-1578"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continual Improvement of the Reliability of EML4-ALK Rearrangement Detection in Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}